Wednesday, November 30, 2022

Research finds that so-called “skinny labeling” which allows drug makers to sell generics for off-patent use saved Medicare around $1.5 billion, but a legal fight could upend the practice. The Center for Medicare and Medicaid Services new Direct Contracting Model saved the agency $70 million during its inaugural year. And CMS is warning hospital systems to do more to protect staff and patients. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.